Navigation Links
National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
Date:9/4/2007

RESTON, Va., Sept. 4 /PRNewswire-USNewswire/ -- The National Pharmaceutical Council (NPC) announced today a new strategic focus on evidence-based medicine (EBM) for health care decision making.

While NPC's overarching mission remains to sponsor and conduct scientific analyses of the appropriate use of pharmaceuticals and the clinical and economic value of pharmaceutical innovation, the focus on EBM represents a new priority for NPC. NPC will be reorganizing and hiring additional staff with the clinical, scientific, and methodological expertise necessary to the focus on EBM.

"NPC has always worked on behalf of the research-based pharmaceutical industry to anticipate pivotal issues, engage with stakeholders to shape workable solutions, and sponsor research to inform choices facing health care decision makers," said Joseph M. Mahady, President of Global Business for Wyeth Pharmaceuticals and NPC Board Chairman. "In prioritizing NPC's activities, the Board unanimously agreed that NPC should focus on evidenced-based coverage and access as the highest priority moving forward."

The new focus on EBM will build on NPC's history of working with researchers, patients, medical professionals, and payers, including employers and government officials. Recent NPC work on EBM has included engagement with the Institute of Medicine Roundtable on Evidence-Based Medicine, the Agency for Healthcare Research and Quality (AHRQ), and the Health Industry Forum. In pursuing its new focus on EBM, NPC will:

-- Facilitate dialogue between the pharmaceutical industry and other

stakeholders;

-- Create awareness and understanding of industry expertise and

perspectives on EBM; and

-- Participate with major stakeholders in the EBM policy debate and

the pursuit of solutions.

Coinciding with the announcement of the new strategic focus, NPC President Karen Williams has announced she will be leaving her current position. According to Mahady, Williams encouraged and guided the Board's adoption of EBM as the focus for NPC and advocated for the reorganization and a search for new leadership. "It's been a privilege to work with the Board and staff, and I'm proud of what we have accomplished," said Ms. Williams.

"Karen has been a terrific resource and leader to the pharmaceutical industry for much of her professional career, especially in her role as NPC's President for the last 11 years," Mahady said. "We will certainly miss her tremendous health policy experience and wisdom, her enthusiasm, drive, and leadership on behalf of NPC and its member companies." Williams has agreed to remain at the helm of NPC during the search for her successor in order to help assure a successful transition.

Mahady said NPC is working with the Washington, DC office of the executive search firm of Korn/Ferry International to direct the search for the next President of the organization. NPC is working with Boyden Executive Search Firm in Atlanta for other senior staff positions, including a Vice President of Clinical and Scientific Affairs and a Research Director.

NPC was established in 1953 and is supported by approximately 20 of the nation's major research-based pharmaceutical companies.

NPC Contact: Pat Adams 703-606-2365; padams@npcnow.com

Korn/Ferry Contact: Lorraine Lavet (202) 955-0943; lorraine.lavet@kornferry.com

Boyden Contact: Deborah Coogan Seltzer 770/618-7655; dseltzer@boyden.com


'/>"/>
SOURCE National Pharmaceutical Council
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. International community warns India on HIV situation
2. National Lung Study in the process
3. Indian Nationals with Foreign Medical Degrees can now practice in India
4. Key step forward on International Health Rules
5. ICMR along with other International Research organisation with drug development for Neglected Diseases
6. International Osteoporosis Research Centre To Be Started In India.
7. Hepatitis B Vaccine To Be Included In National Immunization Programme
8. Indian hospitals require International Accreditation
9. International Conference On Malaria - Laveran To Genomics
10. UK Govt Says On Course For National Chlamydia Screening
11. Delhi To Host International Women’s Congress From Nov 2
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... David J. Dykeman , Ginger ... Traurig, LLP, will speak at DeviceTalks West, Dec. 12, 2016, at the Fairmont Newport ... attorneys from the firm’s global Life Sciences & Medical Technology Group have been featured ...
(Date:12/8/2016)... ... 2016 , ... STATEN ISLAND, N.Y., Nov. 24, 2016 — ... highest standards of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) services ... Daniel Messina. , Among the recognitions, the American College of Surgeons' (ACS) named ...
(Date:12/8/2016)... ... ... Vida Health, the digital health platform that pairs individuals with ... . Other investors include Nokia Growth Partners (NGP) and returning investor Aspect Ventures. Vida ... are managing chronic conditions or simply want to improve their health. Canvas ...
(Date:12/8/2016)... ... , ... Coppin Insurance Agency, an insurance and financial planning firm based in ... area, is embarking on a charity drive with the goal of providing support and ... Food Bank of Southwest Florida works to provide fresh and nutritious food free of ...
(Date:12/7/2016)... Washington,DC (PRWEB) , ... December 07, 2016 , ... ... Forum (NYLF): Medicine will have the unique opportunity to get hands-on experience ... gives high school students an immersive experience to gain invaluable, real-life medical skills ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... 2016  Pennsylvania Physician General Dr. Rachel ... Programs Gary Tennis released safe prescribing ... benzodiazepines, developed with the help of a task ... are frequently prescribed for anxiety or insomnia," said ... opioid pain medications, benzodiazepines pose a significant risk ...
(Date:12/8/2016)... DANVILLE, Pa. , Dec. 8, 2016  A ... physicians reports that the use of opioid therapy to ... actually increase the likelihood of more harmful consequences, including ... Davis , M.D., and Zankhana Mehta , M.D., ... current research on chronic opioid therapy. The study was ...
(Date:12/8/2016)... CAMBRIDGE, Mass. , Dec. 8, 2016 /PRNewswire/ ... that it has obtained proof-of-mechanism for neflamapimod (previously ... recently completed Phase 2a clinical trials that demonstrated ... from Study 302 (12-week treatment) and Study 303 ... the Clinical Trials in Alzheimer,s Disease (CTAD) scientific ...
Breaking Medicine Technology: